Tai-An Lin

Direttore Tecnico/Scientifico/R&S presso SPRINGWORKS THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data 31/05/2024

61 anni

Health Technology

Consumer Services

Profilo

Dr. Tai-An Lin is a Chief Scientific Officer at Springworks Therapeutics, Inc. Dr. Lin was previously employed as a Director-Immuno Oncology Translational by EMD Serono, Inc. and a SVP-Translational Science & Discovery Biology by Black Diamond Therapeutics, Inc. He received his doctorate degree from the University of Missouri.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
SPRINGWORKS THERAPEUTICS, INC. 0.04%	04/01/2024	29 289 ( 0.04% )	1 M $	31/05/2024

Posizioni attive di Tai-An Lin

Società	Posizione	Inizio
SPRINGWORKS THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	11/09/2023

Tutte le posizioni attive di Tai-An Lin

Precedenti posizioni note di Tai-An Lin

Società	Posizione	Fine
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Corporate Officer/Principal	01/09/2019
BLACK DIAMOND THERAPEUTICS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Tai-An Lin

Formazione di Tai-An Lin

University of Missouri

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Tai-An Lin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
SPRINGWORKS THERAPEUTICS, INC.	Health Technology
BLACK DIAMOND THERAPEUTICS, INC.	Health Technology

Aziende private	1
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Health Technology

Vedi le connessioni aziendali